Rosemary Morgan, PhD, is an Associate Scientist at Johns Hopkins Bloomberg School of Public Health in the Department of International Health. Dr. Morgan has expertise in gender, gender analysis, and intersectionality within health and health systems. Some of her current work includes: Leading the Sex and Gender Analysis Core for the NIH funded Sex and Age Differences in Immunity to Influenza (SADII) Center; co-primary investigator on a project exploring the gendered effects of COVID-19 in Bangladesh, Kenya, Nigeria, DRC, and Brazil; co-primary investigator for the project Risk and Resilience in the Health Workforce: Understanding and Supporting the Experiences of Women Health Workers during COVID-19 in British Columbia, Canada; and Gender Equality and Social Inclusion (GESI) advisor for Learning, Acting and Building for Rehabilitation in Health Systems Consortium (ReLAB-HS). She also coordinates an international Gender and COVID-19 Working Group. We discussed differences between gender and sex, how gender bias is embedded in the healthcare system, how COVID-19 and vaccines affect women differently.
Rate, Review & Subscribe!
Carli Sapir is a Founding Partner of Amboy Street Ventures, a venture capital fund investing in Seed and Series A sexual health & women’s health technology startups that are progressing the industry in America and Europe. She is also the Founder...Listen now
AOA is a team of entrepreneurs and experts that bring innovative, impactful and cost-effective medical technologies from research and development into the hands of providers and patients. AOA's mission is to bring to market the first accurate ea...Listen now